Literature DB >> 11525610

Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition.

C D Rudolph, L J Mazur, G S Liptak, R D Baker, J T Boyle, R B Colletti, W T Gerson, S L Werlin.   

Abstract

Gastroesophageal reflux (GER), defined as passage of gastric contents into the esophagus, and GER disease (GERD), defined as symptoms or complications of GER, are common pediatric problems encountered by both primary and specialty medical providers. Clinical manifestations of GERD in children include vomiting, poor weight gain, dysphagia, abdominal or substernal pain, esophagitis and respiratory disorders. The GER Guideline Committee of the North American Society for Pediatric Gastroenterology and Nutrition has formulated a clinical practice guideline for the management of pediatric GER. The GER Guideline Committee, consisting of a primary care pediatrician, two clinical epidemiologists (who also practice primary care pediatrics) and five pediatric gastroenterologists, based its recommendations on an integration of a comprehensive and systematic review of the medical literature combined with expert opinion. Consensus was achieved through Nominal Group Technique, a structured quantitative method. The Committee examined the value of diagnostic tests and treatment modalities commonly used for the management of GERD, and how those interventions can be applied to clinical situations in the infant and older child. The guideline provides recommendations for management by the primary care provider, including evaluation, initial treatment, follow-up management and indications for consultation by a specialist. The guideline also provides recommendations for management by the pediatric gastroenterologist. This document represents the official recommendations of the North American Society for Pediatric Gastroenterology and Nutrition on the evaluation and treatment of gastroesophageal reflux in infants and children. The American Academy of Pediatrics has also endorsed these recommendations. The recommendations are summarized in a synopsis within the article. This review and recommendations are a general guideline and are not intended as a substitute for clinical judgment or as a protocol for the management of all patients with this problem.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11525610     DOI: 10.1097/00005176-200100002-00001

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  119 in total

1.  The presence of pepsin in the lung and its relationship to pathologic gastro-esophageal reflux.

Authors:  R Rosen; N Johnston; K Hart; U Khatwa; S Nurko
Journal:  Neurogastroenterol Motil       Date:  2011-12-05       Impact factor: 3.598

Review 2.  Pediatric otolaryngologic manifestations of gastroesophageal reflux disease.

Authors:  Mark A Gilger
Journal:  Curr Gastroenterol Rep       Date:  2003-06

Review 3.  GERD in the pediatric patient: management considerations.

Authors:  David A Gremse
Journal:  MedGenMed       Date:  2004-05-05

4.  European multicenter survey on the laparoscopic treatment of gastroesophageal reflux in patients aged less than 12 months with supraesophageal symptoms.

Authors:  G Mattioli; K Bax; F Becmeur; C Esposito; Y Heloury; G Podevin; M Lima; G A MacKinlay; A Goessler; J A Tovar; J Valla; P Tuo; L Nahum; G Ottonello; O Sacco; V Gentilino; A Pini-Prato; E Caponcelli; V Jasonni
Journal:  Surg Endosc       Date:  2005-08-11       Impact factor: 4.584

Review 5.  Outcomes of fundoplication: causes for concern, newer options.

Authors:  E Hassall
Journal:  Arch Dis Child       Date:  2005-10       Impact factor: 3.791

6.  Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines.

Authors:  Richard S Irwin; Michael H Baumann; Donald C Bolser; Louis-Philippe Boulet; Sidney S Braman; Christopher E Brightling; Kevin K Brown; Brendan J Canning; Anne B Chang; Peter V Dicpinigaitis; Ron Eccles; W Brendle Glomb; Larry B Goldstein; LeRoy M Graham; Frederick E Hargreave; Paul A Kvale; Sandra Zelman Lewis; F Dennis McCool; Douglas C McCrory; Udaya B S Prakash; Melvin R Pratter; Mark J Rosen; Edward Schulman; John Jay Shannon; Carol Smith Hammond; Susan M Tarlo
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

7.  16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal microflora.

Authors:  Rachel Rosen; Lan Hu; Janine Amirault; Umakanth Khatwa; Doyle V Ward; Andrew Onderdonk
Journal:  J Pediatr       Date:  2015-02-04       Impact factor: 4.406

8.  Children with cystic fibrosis have prolonged chemical clearance of acid reflux compared to symptomatic children without cystic fibrosis.

Authors:  Frederick W Woodley; Rodrigo S Machado; Don Hayes; Carlo Di Lorenzo; Ajay Kaul; Beth Skaggs; Karen McCoy; Alpa Patel; Hayat Mousa
Journal:  Dig Dis Sci       Date:  2013-11-28       Impact factor: 3.199

9.  Proton pump inhibitor prescribing patterns in newborns and infants.

Authors:  Marta Illueca; Berhanu Alemayehu; Nze Shoetan; Huiying Yang
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

10.  Pediatric specialists' beliefs about gastroesophageal reflux disease in premature infants.

Authors:  Catherine A Golski; Ellen S Rome; Richard J Martin; Scott H Frank; Sarah Worley; Zhiyuan Sun; Anna Maria Hibbs
Journal:  Pediatrics       Date:  2009-12-14       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.